Century Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 50.3% | 55.4% | -50.2% |
| FY2021 | -24.2% | -23.7% | -21.9% |
| FY2022 | -43.2% | -42.7% | -26.9% |
| FY2023 | -74.0% | -74.0% | -37.9% |
| FY2024 | -78.4% | -78.4% | -35.8% |
| FY2025 | -6.0% | -6.0% | -4.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 50.3% | 55.4% | -50.2% |
| FY2021 | -24.2% | -23.7% | -21.9% |
| FY2022 | -43.2% | -42.7% | -26.9% |
| FY2023 | -74.0% | -74.0% | -37.9% |
| FY2024 | -78.4% | -78.4% | -35.8% |
| FY2025 | -6.0% | -6.0% | -4.3% |